by Khaled M. Musallam, Vijay G

Slides:

Advertisements

Similar presentations

JAK2V617F mutation for the early diagnosis of Ph − myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis by Francesco Dentali,

Advertisements

Iron Overload in NTDT 3rd Pan-European Conference on Haemoglobinopathies & Rare Anaemias Limassol, 24 – 26 October 2012 Khaled M. Musallam, MD, PhD American.

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas by Amrita Krishnan, Arturo Molina, John Zaia, David.

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma by Joshua Richter, Natalia Neparidze,

An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe −/− mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Formation of human hepatocytes by human hematopoietic stem cells in sheep by Graça Almeida-Porada, Christopher D. Porada, Jason Chamberlain, Ali Torabi,

Determination of acute lung injury after repeated platelet transfusions by Laurence Corash, Jin Sying Lin, Claire D. Sherman, and Joseph Eiden Blood Volume.

Iron overload and chelation therapy in myelodysplastic syndromes

The influence of high-altitude living on body iron

Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts by Boglarka Gyurkocza,

by Dai Chida, Osamu Miura, Akihiko Yoshimura, and Atsushi Miyajima

Fetal Hemoglobin in Starvation Ketosis of Young Women

Pocket-sized iron regulators: one size fits all?

Quantitative trait locus on chromosome 8q influences the switch from fetal to adult hemoglobin by Chad Garner, Nicholas Silver, Steve Best, Stephan Menzel,

Next-generation leukemia immunotherapy

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

by Sandra Luna-Fineman, Kevin M. Shannon, Susan K

Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and.

Tax fingerprint in adult T-cell leukemia

Desferrioxamine-chelatable iron, a component of serum non–transferrin-bound iron, used for assessing chelation therapy by William Breuer, Marieke J. J.

Nonmyeloablative conditioning for relapsed follicular lymphoma

by Ali Imran Amjad, and Rahul A. Parikh

Fusion genes in cord blood

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients by William J. Hogan,

What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):

Deep mining of the RBC proteome

Reproductive capacity in iron overloaded women with thalassemia major

by Alexander Röth, Andreas Hüttmann, Russell P

The origins of age-related proinflammatory state

Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients.

Β2-glycoprotein I–dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome by H. Bas de Laat, Ronald H.W.M. Derksen,

Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development.

by Jayesh Mehta Blood Volume 112(2): July 15, 2008

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma by Robert Marcus, Kevin Imrie, Andrew Belch,

Incidence and Predictors Of Venous Thromboembolism Among Lymphoma Patients In Denmark: A Nationwide Population-Based Cohort Study by Jennifer L Lund, Lene.

Yang et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood. 2008;112(3):805–813. Blood Volume 114(14): October.

Anergy: the CLL cell limbo

Sabina Hunziker, MD, MPH, Jennifer Stevens, MD, MS, Michael D

by John J. Strouse, Megan E. Reller, David G

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.

Volume 87, Issue 1, Pages (January 2015)

Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case–control study using electronic records by Elizabeth.

Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality.

Holly R. Martin, Michele D. Poe, James M

Association of total disease burden and disease progression with age‐adjusted blood heteroplasmy Association of total disease burden and disease progression.

Blood transfusion balance: Too much, not enough, or just right

Do CIs Give You Confidence?

Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.

Forest plot of adjusted odds ratios (with 95% confidence intervals) from multivariable multinomial logistic regression analysis (table 4), by number of.

Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.

Mammen Chandy Biology of Blood and Marrow Transplantation

Davide Capodanno et al. JCIN 2009;2:

Increase in adults treated at children's hospitals, 1999–2012, according to age group. Increase in adults treated at children's hospitals, 1999–2012, according.

Increase in adults treated at children's hospitals, 1999–2012, according to age group and disease. Increase in adults treated at children's hospitals,

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Sickle cells and sickle trait in thrombosis

Khadijah Breathett et al. JCHF 2017;5:

Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.

Time-dependent survival estimation in post–polycythemia vera myelofibrosis. Time-dependent survival estimation in post–polycythemia vera myelofibrosis.

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Volume 24, Issue 1, Pages 7-8 (July 2016)

Brooks A. Keel, Ph.D., H.C.L.D.(A.B.B.) Fertility and Sterility

Pure red cell aplasia by Robert T. Means Blood

by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio

Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.

Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia by Mohamed Bradai, Mohand Tayeb Abad, Serge Pissard, Fatima Lamraoui,

Balancing bleeding in brain metastases

Cold agglutinin disease

Presentation transcript:

Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia by Khaled M. Musallam, Vijay G. Sankaran, Maria Domenica Cappellini, Lorena Duca, David G. Nathan, and Ali T. Taher Blood Volume 119(2):364-367 January 12, 2012 ©2012 by American Society of Hematology

Association between fetal hemoglobin level and the morbidity score. Association between fetal hemoglobin level and the morbidity score. Figures show linear regression of (A) fetal hemoglobin level and (B) log fetal hemoglobin level against the morbidity score. Tables represent results of linear regression analysis after adjustment for indicated variables. NRBC indicates nucleated red blood cell; GDF, growth differentiation factor; NTBI, non–transferrin-bound iron; and CI, confidence interval. Khaled M. Musallam et al. Blood 2012;119:364-367 ©2012 by American Society of Hematology